Targeting immunotherapy using the avidin-biotin system for a human colon adenocarcinoma in vitro

Journal of International Medical Research

Volumn 25, Issue 1, 1997, Pages 14-23

  Nakaki, M ^a   Takikawa, H ^a   Yamanaka, M ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Alamar blue assay; Anti carcinoembryonic antigen monoclonal antibody; Avidin biotin system; Cytotoxicity; Neocarzinostatin

Indexed keywords

ANTINEOPLASTIC AGENT; AVIDIN; BIOTIN; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL ANTIBODY; ZINOSTATIN;

ARTICLE; CANCER CELL CULTURE; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INCUBATION TIME;

EID: 0031015822     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059702500103     Document Type: Article

References (27)

1. Takahashi H, Nakada T, Puisieux I: Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice. Science 1993; 259: 1460-1463.
2. Takahashi H, Nakada T, Nakaki M, et al: Inhibition of hepatic metastases of human colon cancer in nude mice by a chimeric SF-25 monoclonal antibody. Gastroenterology 1995; 108: 172-182.
3. Oikawa S, Imajo S, Noguchi T, et al: The carcinoembryonic antigen (CEA) contains multiple immunoglobulin-like domains. Biochem Biophys Res Commun 1987; 144: 634-642.
4. Paxton RJ, Mooser G, Pande H, et al: Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family. Proc Natl Adac Sci USA 1987; 84: 920-924.
5. Ishida N, Miyazaki K, Kumagai K, et al: Neocarzinostatin, an antitumor antibiotic of high molecular weight. J Antibiot (Tokyo) Ser A 1965; 18: 68-76.
6. Maeda H, Kumagai K, Ishida N: Characterization of neocarzinostatin. J Antibiot (Tokyo) Ser A 1966; 19: 253-259.
7. Hiraki K, Kamimura O, Takahashi I, et al: Neocarzinostatin, a new chemotherapeutic approach to acute leukemia. Nouv Rev Fr Hematatol 1973; 13: 445-451.
8. Takahashi M, Toriyama K, Maeda H, et al: Clinical trials of a new antitumor polypeptide: neocarzinostatin (NCS). Tohoku J Exp Med 1969; 98: 273-280.
9. Meienhofer J, Maeda H, Glaser CB, et al: Primary structure of neocarzinostatin, an antitumor protein. Science 1972; 178: 875-876.
10. Tatsumi K, Nakamura T, Wakisaka G, et al: Damage of mammalian cell DNA in vivo and in vitro induced by neocarzinostatin. Gann 1974; 65: 459-461
11. Green NM: A spectrophotometric assay for avidin and biotin on binding of dyes by avidin. Biochem J 1965; 94: 23C-24C.
12. Paganelli G, Malcovati M, Fazio F, et al: Monoclonal antibody pretargeting techniques for tumor localization: the avidin-biotin system. Nucl Med Commun 1991; 12: 211-234.
13. Paganelli G, Pervez S, Siccardi AG, et al: Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies. Int J Cancer 1990; 45: 1184-1189.
14. Paganelli G, Malcovati M, Zito F, et al: Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res 1991; 51: 5960-5966.
15. Hnatowich DJ, Virizi F, Rusckowski M: Investigations of avidin and biotin for imaging applications. J Nucl Med 1987; 28: 1294-1302.
16. Page B, Page M, Noel C: A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol 1993; 3: 473-476.
17. Drewinko B, Romsdahl MM, Yang YL, et al: Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res 1976; 36: 467-475.
18. Warnke R, Levy R: Detection of T and B cell antigens with hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. J Histochem Cytochem 1980; 28: 771-776.
19. Kumagaya Y, Okumura Y: Immunofluorescence staining by using biotin-binding protein (avidin). In Methods of Immunological Experimentation 8th ed. Kanazawa City: Japanese Immunology Society 1979; pp2425 - 2430. In Japanese.
20. Fujita H, Nakayama N, Sawabe T: In vivo distribution and inactivation of neocarzinostatin. Jpn J Antibiotics 1970; 23: 471-478.
21. Takahashi T, Yamaguchi T, Kitamura K: Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma. Cancer 1988; 61: 881-888.
22. Maeda H, Takeshita J, Kanamaru R: A lipophilic derivative of neocarzinostatin, a polymer conjugation of antibiotic protein. Int J Pept Protein Res 1979; 14: 81-87.
23. Vladimir VS, Anna GM, Yelena YC, et al: Rapid blood clearance of biotinylated IgG after infusion of avidin. J Nucl Med 1989; 30: 66-69.
24. Reynolds JC, Vecchio SD, Sakahara H, et al: Anti-murine antibody response to mouse monoclonal antibodies: clinical findings and implications. Int J Radiat Appl instrum part B. 1989; 16: 121-125.
25. Reichmann L, Clark M, Waldmann G, et al: Reshaping human antibodies for therapy. Nature 1988; 332: 323-327.
26. Man C, Marguriye D, Richad W, et al: Humanized antibodies for antiviral therapy. Proc Natl Acad Sci USA 1991; 88: 2869-2873.
27. Nakata K, Nagataki S: Radioimmunoimaging with monoclonal antibodies. Jpn J Clin Med 1990; 48: 1036-1042. In Japanese.